Free Trial
NYSE:AMPE

Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis

Ampio Pharmaceuticals logo
$0.0030 0.00 (0.00%)
As of 05/23/2025

About Ampio Pharmaceuticals Stock (NYSE:AMPE)

Key Stats

Today's Range
$0.0030
$0.0030
50-Day Range
N/A
52-Week Range
$0.00
$0.45
Volume
6 shs
Average Volume
435 shs
Market Capitalization
$3,405.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

Receive AMPE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AMPE Stock News Headlines

Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Ampio Pharmaceuticals, Inc. (AMPE)
See More Headlines

AMPE Stock Analysis - Frequently Asked Questions

Ampio Pharmaceuticals' stock was trading at $0.0026 at the beginning of 2025. Since then, AMPE shares have increased by 15.4% and is now trading at $0.0030.
View the best growth stocks for 2025 here
.

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) released its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.40) earnings per share for the quarter, meeting the consensus estimate of ($0.40).

Ampio Pharmaceuticals shares reverse split on the morning of Tuesday, September 12th 2023. The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ampio Pharmaceuticals investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), Trevena (TRVN), GE Aerospace (GE) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
11/10/2021
Today
5/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:AMPE
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$4.04 per share
Price / Book
0.00

Miscellaneous

Free Float
1,098,000
Market Cap
$3,405.00
Optionable
No Data
Beta
3.90
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NYSE:AMPE) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners